or Try an Advanced Search...

    Technical Analysis for GOSS - Gossamer Bio, Inc.

    Grade Last Price % Change Price Change
    B 0.95 5.18% 0.05
    GOSS closed up 5.18 percent on Monday, July 1, 2024, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical GOSS trend table...
    Date Alert Name Type % Chg
    180 Bullish Setup Bullish Swing Setup 0.00%
    Boomer Buy Setup Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Calm After Storm Range Contraction 5.18%
    Upper Bollinger Band Walk Strength 5.18%
    Inside Day Range Contraction 5.18%
    Wide Bands Range Expansion 5.18%
    Older End-of-Day Signals for GOSS ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 5 hours ago
    Up 5% about 5 hours ago
    Possible NR7 about 7 hours ago
    Possible Inside Day about 7 hours ago
    Up 3% about 11 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    GOSS Chart by TradingView
    Basic chart:

    Profile

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Life Sciences Disease Immunology Inflammation Millennium Pharmaceuticals

    Is GOSS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 25 Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
    Jun 25 Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
    Jun 24 Gossamer Bio a new outperform at Oppenheimer on seralutinib for PAH
    Jun 13 The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
    Jun 7 Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    May 14 Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
    May 7 Gossamer Bio GAAP EPS of -$0.19 in-line
    May 7 Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
    May 7 Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
    May 6 Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
    See more GOSS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.88
    52 Week Low 0.4525
    Average Volume 2,542,768
    200-Day Moving Average 0.86
    50-Day Moving Average 0.68
    20-Day Moving Average 0.66
    10-Day Moving Average 0.79
    Average True Range 0.09
    RSI (14) 69.23
    ADX 46.43
    +DI 37.65
    -DI 6.72
    Chandelier Exit (Long, 3 ATRs) 0.81
    Chandelier Exit (Short, 3 ATRs) 0.78
    Upper Bollinger Bands 1.02
    Lower Bollinger Band 0.31
    Percent B (%b) 0.9
    BandWidth 107.61
    MACD Line 0.07
    MACD Signal Line 0.02
    MACD Histogram 0.0513
    Fundamentals Value
    Market Cap 213.6 Million
    Num Shares 225 Million
    EPS -1.60
    Price-to-Earnings (P/E) Ratio -0.59
    Price-to-Sales 0.00
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.04
    Resistance 3 (R3) 1.03 0.99 1.02
    Resistance 2 (R2) 0.99 0.97 0.99 1.02
    Resistance 1 (R1) 0.97 0.95 0.98 0.98 1.01
    Pivot Point 0.93 0.93 0.93 0.93 0.93
    Support 1 (S1) 0.91 0.91 0.92 0.92 0.88
    Support 2 (S2) 0.87 0.89 0.87 0.88
    Support 3 (S3) 0.85 0.87 0.87
    Support 4 (S4) 0.86